Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ACELYRIN Inc SLRN

ACELYRIN, INC. is a late-stage clinical biopharma company. The Company is focused on providing treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The Company has two programs in late-stage clinical development. The Company’s lead product candidate, izokibep, is being evaluated in multiple immunologic indications... see more

Recent & Breaking News (NDAQ:SLRN)

INVESTOR ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 16, 2024 in Acelyrin Lawsuit - SLRN

Accesswire December 7, 2023

SLRN SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ACELYRIN, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire December 7, 2023

SHAREHOLDER ALERT: Contact Levi & Korsinsky Before January 16, 2024 to Discuss Your Rights - SLRN

Accesswire December 7, 2023

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses of $100,000 to Contact the Firm

Accesswire December 7, 2023

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Acelyrin, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SLRN

Accesswire December 6, 2023

Acelyrin Shareholder Notice

Newsfile December 6, 2023

HAGENS BERMAN Encourages Acelyrin (SLRN) Investors with Substantial Losses to Contact Firm's Attorneys, Securities Fraud Lawsuit Filed over Drug Candidate's Progress

Accesswire December 6, 2023

Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against Acelyrin, Inc. (SLRN) and Encourages Investors with Significant Losses to Contact the Firm

Accesswire December 6, 2023

INVESTOR ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 16, 2024 in Acelyrin Lawsuit - SLRN

Accesswire December 6, 2023

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses of $100,000 to Contact the Firm

Newsfile December 6, 2023

SHAREHOLDER ALERT: Levi & Korsinsky Reminds Acelyrin, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2024 - SLRN

Accesswire December 6, 2023

SLRN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ACELYRIN, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire December 6, 2023

INVESTOR ALERT: Contact Levi & Korsinsky Before January 16, 2024 to Discuss Your Rights - SLRN

Accesswire December 6, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACELYRIN, Inc. of Class Action Lawsuit and Upcoming Deadline - SLRN

Newsfile December 6, 2023

INVESTOR ALERT: Levi & Korsinsky Notifies Shareholders of Acelyrin, Inc.(SLRN) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire December 6, 2023

INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ACELYRIN, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire December 6, 2023

INVESTOR ALERT: Levi & Korsinsky Notifies Acelyrin, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SLRN

Accesswire December 6, 2023

FINAL DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Acelyrin, Inc. with Losses of $100,000 to Contact the Firm

Accesswire December 6, 2023

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Acelyrin, Inc.(SLRN) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire December 5, 2023

INVESTOR ALERT: Levi & Korsinsky Notifies Shareholders of Acelyrin, Inc.(SLRN) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire December 5, 2023